Lipid technology for delivery of gene editing therapies

Insightful whitepaper looking into how gene-editing technology is moving from the research lab to the clinic, one of the most eagerly anticipated biopharma developments in recent history. One of the biggest hurdles to the development of successful gene-editing therapeutics is effective delivery of the large and sensitive components needed to execute the editing functions. Lipid-based nanoparticles present promising solutions to these challenges.